Erion, Mark D.
Janssen Research & Development,
Belgium
2025 Rank: 146026
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 530 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146026 | 132685 |
| Total Cites | 6260 | 6993 |
| H-index | 46 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1198 | 1402 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 4001 | 4475 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4756 | 5014 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
10.48%
|
|
Erion, Mark D.
Merck & Co., Inc.,
United States
2024 Rank: 141043
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 512 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141043 | 127274 |
| Total Cites | 5859 | 6610 |
| H-index | 45 | 48 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1143 | 1353 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 3814 | 4308 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4429 | 4684 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.41 |
| Self-Citation Percentage |
11.36%
|
|
Erion, Mark D.
Merck & Co., Inc.,
United States
2023 Rank: 134921
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 486 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 134921 | 121720 |
| Total Cites | 5530 | 6270 |
| H-index | 44 | 46 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1105 | 1315 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 3660 | 4154 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4157 | 4403 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.42 |
| Self-Citation Percentage |
11.80%
|
|
Erion, Mark D.
Merck & Co., Inc.,
United States
2022 Rank: 125845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 446 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125845 | 113186 |
| Total Cites | 5175 | 5895 |
| H-index | 43 | 45 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1064 | 1274 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 3496 | 3990 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3848 | 4079 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.45 |
| Self-Citation Percentage |
12.21%
|
|
Erion, Mark D.
Merck & Co., Inc.,
United States
2021 Rank: 122230
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 455 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122230 | 108182 |
| Total Cites | 5003 | 5684 |
| H-index | 42 | 45 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1039 | 1241 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 3421 | 3888 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3692 | 3915 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.45 |
| Self-Citation Percentage |
11.98%
|
|
Erion, Mark D.
Merck & Co., Inc.,
United States
2020 Rank: 116065
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 543 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116065 | 103377 |
| Total Cites | 4557 | 5222 |
| H-index | 40 | 43 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 992 | 1194 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 3215 | 3682 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3333 | 3542 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.47 |
| Self-Citation Percentage |
12.73%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.